BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 33877321)

  • 1. A Cytokine/Bradykinin Storm Comparison: What Is the Relationship Between Hypertension and COVID-19?
    Wilczynski SA; Wenceslau CF; McCarthy CG; Webb RC
    Am J Hypertens; 2021 Apr; 34(4):304-306. PubMed ID: 33877321
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular Manifestations and Mechanisms in Patients with COVID-19.
    Dou Q; Wei X; Zhou K; Yang S; Jia P
    Trends Endocrinol Metab; 2020 Dec; 31(12):893-904. PubMed ID: 33172748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOX-Dependent Signaling Dysregulation in Severe COVID-19: Clues to Effective Treatments.
    Damiano S; Sozio C; La Rosa G; Santillo M
    Front Cell Infect Microbiol; 2020; 10():608435. PubMed ID: 33384971
    [No Abstract]   [Full Text] [Related]  

  • 4. The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury.
    Zarrilli G; Angerilli V; Businello G; Sbaraglia M; Traverso G; Fortarezza F; Rizzo S; De Gaspari M; Basso C; Calabrese F; Dei Tos AP; Fassan M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Vascular Endothelium in the Treatment of COVID-19.
    Suvorava T; Kaesemeyer W
    J Cardiovasc Pharmacol; 2021 Jan; 77(1):1-3. PubMed ID: 33079828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not so sweet and simple: impacts of SARS-CoV-2 on the β cell.
    Ibrahim S; Monaco GSF; Sims EK
    Islets; 2021 Jul; 13(3-4):66-79. PubMed ID: 33970787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol, inflammation, and phospholipids: COVID-19 share traits with cardiovascular disease.
    Pimentel LL; Rodríguez-Alcalá LM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158839. PubMed ID: 33080357
    [No Abstract]   [Full Text] [Related]  

  • 8. Delving Into the Origin of Destructive Inflammation in COVID-19: A Betrayal of Natural Host Defense Peptides?
    Garcia-Fandino R; Piñeiro Á
    Front Immunol; 2020; 11():610024. PubMed ID: 33552069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19?
    Karamyan VT
    Physiol Rep; 2021 Mar; 9(5):e14796. PubMed ID: 33687143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the measurement of vascular function and structure in isolated arteries and veins.
    Wenceslau CF; McCarthy CG; Earley S; England SK; Filosa JA; Goulopoulou S; Gutterman DD; Isakson BE; Kanagy NL; Martinez-Lemus LA; Sonkusare SK; Thakore P; Trask AJ; Watts SW; Webb RC
    Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H77-H111. PubMed ID: 33989082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning.
    Patel MA; Daley M; Van Nynatten LR; Slessarev M; Cepinskas G; Fraser DD
    Clin Proteomics; 2024 May; 21(1):33. PubMed ID: 38760690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against Severe Illness versus Immunity-Redefining Vaccine Effectiveness in the Aftermath of COVID-19.
    Roche R; Odeh NH; Andar AU; Tulapurkar ME; Roche JA
    Microorganisms; 2023 Jul; 11(8):. PubMed ID: 37630523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases.
    Neves RL; Branquinho J; Arata JG; Bittencourt CA; Gomes CP; Riguetti M; da Mata GF; Fernandes DE; Icimoto MY; Kirsztajn GM; Pesquero JB
    Inflamm Res; 2023 Aug; 72(8):1719-1731. PubMed ID: 37537367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of noscapine-licorice combination effects on cough relieving in COVID-19 outpatients: A randomized controlled trial.
    Barati S; Feizabadi F; Khalaj H; Sheikhzadeh H; Jamaati HR; Farajidavar H; Dastan F
    Front Pharmacol; 2023; 14():1102940. PubMed ID: 36873992
    [No Abstract]   [Full Text] [Related]  

  • 15. Exome-Wide Association Study Reveals Host Genetic Variants Likely Associated with the Severity of COVID-19 in Patients of European Ancestry.
    Upadhyai P; Shenoy PU; Banjan B; Albeshr MF; Mahboob S; Manzoor I; Das R
    Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Bradykinin System Contributes to the Regulation of Prostaglandin-Endoperoxide Synthase 2 Expression in Human Amnion Fibroblasts: Implications for Term and Preterm Birth.
    Ni XT; Wang WS; Liu Y; Lin YK; Zhang F; Lei WJ; Ling LJ; Pan F; Zhu YN; Li MD; Duan T; Liu M; Sun K
    Front Endocrinol (Lausanne); 2022; 13():873727. PubMed ID: 35634493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D Regulation of Immune Function.
    Bikle DD
    Curr Osteoporos Rep; 2022 Jun; 20(3):186-193. PubMed ID: 35507293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and COVID-19: Updates from the era of vaccines and variants.
    Swamy S; Koch CA; Hannah-Shmouni F; Schiffrin EL; Klubo-Gwiezdzinska J; Gubbi S
    J Clin Transl Endocrinol; 2022 Mar; 27():100285. PubMed ID: 34900602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modular map of Bradykinin-mediated inflammatory signaling network.
    Rex DAB; Deepak K; Vaid N; Dagamajalu S; Kandasamy RK; Flo TH; Keshava Prasad TS
    J Cell Commun Signal; 2022 Jun; 16(2):301-310. PubMed ID: 34714516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease.
    Khan M; Singh GK; Abrar S; Ganeshan R; Morgan K; Harky A
    Expert Opin Pharmacother; 2021 Dec; 22(18):2455-2474. PubMed ID: 34464223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.